Brian Schwartz - 07 Sep 2021 Form 4 Insider Report for INFINITY PHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Brian Schwartz
Issuer symbol
N/A
Transactions as of
07 Sep 2021
Net transactions value
$0
Form type
4
Filing time
10 Sep 2021, 12:35:24 UTC
Previous filing
17 Jun 2021
Next filing
16 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFI Stock Option (right to buy) Award $0 +60,000 $0.000000 60,000 07 Sep 2021 Common Stock 60,000 $3.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 . The option vests as to 1/8th of the total number of shares on September 30, 2021 and as to 1/8th of the total number of shares at the end of each calendar quarter thereafter, provided that the Reporting Person continues to serve as a director of the Issuer.